IP Library Granted Patent US 11,524,171
Granted Patent B2
US 11,524,171 · App. 16/827,330 · Granted Dec 13, 2022

Aesthetic method of biological structure treatment by magnetic field

Inventors: Tomas Schwarz (Prague, CZ); Ondra Prouza (Ricany u Prahy, CZ)
Assignee: BTL Medical Solutions A.S.
A61N2/02A61F7/007A61F7/0053A61N2/004A61F2007/0056A61F2007/0075A61F2007/029
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,524,171
App. No.
16/827,330
Granted
Dec 13, 2022
Kind
B2
Abstract

In methods for treating a patient, a time varying magnetic field is applied to a patient's body and causes a muscle contraction. The time-varying magnetic field may be monophasic, biphasic, polyphasic and/or static. The method may reduce adipose tissue, improve metabolism, blood and/or lymph circulation. The method may use combinations of treatments to enhance the visual appearance of the patient.

Claims (29)

1. A treatment device for providing a first treatment and a second treatment to a patient, the treatment device comprising:

a power supply;

a control unit connected to the power supply;

a magnetic field generating coil connected to the power supply and configured to provide the first treatment, wherein the first treatment comprises generating a time-varying magnetic field having magnetic impulses, and wherein the magnetic impulses have an impulse duration in a range of 3 μs to 3 ms, a repetition rate in a range of 1 Hz to 300 Hz, and a magnetic flux density derivative having a maximal value in a range of 0.3 kT/s to 800 kT/s; and

at least one of an RF electrode, an optical waves generating device, or a cooling element configured to provide the second treatment,

wherein the first treatment is configured to be applied to the patient, such that it causes muscle contractions in a body region of the patient, and

wherein the second treatment comprises a thermal treatment.

2. The device of claim 1 , wherein the power supply comprises a plug.

3. The device of claim 1 , further comprising a transmatch,

wherein the treatment device comprises the RF electrode, and

wherein the transmatch is configured to provide an optimized signal to the RF electrode.

4. The device of claim 1 , further comprising a high frequency generator and a balun, wherein the balun is configured to transform an unbalanced signal from the high frequency generator to a balanced signal.

5. The device of claim 1 , wherein the treatment device comprises the RF electrode, and wherein the magnetic field generating coil is encircled by the RF electrode.

6. The device of claim 1 , wherein the treatment device comprises the RF electrode, and wherein the magnetic field generating coil is wound around the RF electrode.

7. The device of claim 1 , wherein the magnetic field generating coil is enclosed in an applicator.

8. The device of claim 7 , wherein the applicator comprises the at least one of the RF electrode, the optical waves generating device, or the cooling element.

9. The device of claim 7 , wherein the treatment device further comprises a second applicator including at least one of an RF electrode or an optical waves generating device.

10. The device of claim 1 , wherein the treatment device comprises the optical waves generating device, and wherein the optical waves generating device is configured to generate optical waves having a power flux density in a range of 0.1 W/cm 2 to 100 W/cm 2 .

11. The device of claim 1 , wherein the treatment device comprises the optical waves generating device, and wherein the optical waves generating device is configured to generate optical waves having an optical energy flux density in a range of 1 J/cm 2 to 50 J/cm 2 .

12. The device of claim 1 , wherein the treatment device comprises the optical waves generating device, and wherein the optical waves generating device is configured to generate optical waves having a wavelength in a range of 200 nm to 300 nm, 400 to 600 nm, 780 nm to 980 nm, 1050 nm to 1100 nm, or 1300 to 1450 nm.

13. The device of claim 1 , wherein the treatment device comprises the optical waves generating device, and wherein the optical waves generating device is configured to generate optical waves for heating adipose cells of the patient to a temperature in a range of 37.5° C. to 60° C.

14. The device of claim 1 , wherein the treatment device comprises the optical waves generating device, and wherein the optical waves generating device is a monochromatic optical waves generating device.

15. The device of claim 1 , wherein the treatment device comprises the cooling element, and wherein the cooling element has a temperature in a range of 20° C. to −20° C.

16. The device of claim 1 , wherein the treatment device comprises the cooling element, and wherein the cooling element comprises a thermally conductive material.

17. The device of claim 1 , wherein the treatment device further comprises the cooling element, and wherein the cooling element comprises a Peltier cooler.

18. The device of claim 1 , wherein the treatment device further comprises the cooling element, wherein the cooling element comprises a cooling media, and wherein the treatment device further comprises a pump configured to move the cooling media.

19. The device of claim 1 , further comprising a plurality of applicators, wherein each of the plurality of applicators is independently positionable, and wherein one applicator of the plurality of applicators comprises the magnetic field generating coil.

20. The device of claim 1 , wherein the magnetic field generating coil is enclosed within a first applicator, wherein the device further comprises a second magnetic field generating coil enclosed within a second applicator, the second magnetic field generating coil configured to generate a second time-varying magnetic field, and

wherein the first magnetic field generating coil and the second magnetic field generating coil are controlled by the control unit in order to generate the first time-varying magnetic field and the second time-varying magnetic field independently.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2022
From: BTL HEALTHCARE TECHNOLOGIES A.S.
To: BTL MEDICAL SOLUTIONS A.S.
Reel/Frame 061347/0644 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2022
From: BTL HEALTHCARE TECHNOLOGIES A.S.
To: BTL MEDICAL SOLUTIONS A.S.
Reel/Frame 063272/0050 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2021
From: BTL MEDICAL TECHNOLOGIES S.R.O.
To: BTL HEALTHCARE TECHNOLOGIES A.S.
Reel/Frame 056526/0492 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2020
From: PROUZA, ONDRA
To: BTL MEDICAL TECHNOLOGIES S.R.O.
Reel/Frame 052998/0805 →
MERGER Recorded Jun 22, 2020
From: MEDICAL TECHNOLOGIES CZ A.S.
To: BTL MEDICAL TECHNOLOGIES S.R.O.
Reel/Frame 052998/0318 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2020
From: SCHWARZ, TOMÁS
To: BTL HOLDINGS LIMITED
Reel/Frame 052997/0821 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2020
From: BTL HOLDINGS LIMITED
To: MEDICAL TECHNOLOGIES CZ A.S.
Reel/Frame 052998/0078 →
Continuity (5)
Continuation 15601719 · May 22, 2017
Provisional Application 62440922 · Dec 30, 2016
Provisional Application 62440905 · Dec 30, 2016
Provisional Application 62357679 · Jul 1, 2016
Related Publication 20200289838A1 · Sep 17, 2020